文献速递乳腺癌放疗放疗物理与技术

计划CT检测的心脏钙化密度与体积预测大分割全乳放疗后心脏毒性

Density and volume of cardiac calcifications detected on planning CT predicts cardiotoxicity after hypo-fractionated whole breast Radiotherapy.
PubMed 文献 · Radiother Oncol · 2025-08-10

本研究纳入1172例接受3DCRT全乳放疗(40 Gy/15次)的连续患者,评估心脏钙化积分与心脏事件的关系。Agatson积分、钙化体积和心脏最大HU值均为高度显著预测因子(p<0.005),多变量模型结合MHD>1 Gy、年龄和钙化评分(AUC=0.77/0.755)。Max_HU有望快速评估风险患者。

要点

  • 心脏钙化是心脏毒性的最重要预测因子,Agatson积分、钙化体积和Max_HU均高度显著。
  • MHD仅在按Youden指数最佳截断值(MHD>1 Gy)编码时具有预测价值。
  • 左乳腺癌伴中重度钙化(Max_HU>250)患者从进一步心脏保护中获益最大。

核心结论

  • 心脏钙化是心脏毒性的最重要预测因子,Max_HU有望用于快速评估风险患者。

研究设计与样本

  • 单中心回顾性队列研究,纳入1172例连续接受3DCRT全乳放疗(40 Gy/15次)的患者。
  • 心脏自动分割并计算平均心脏剂量(MHD),用自研脚本评估Agatson积分、钙化体积和心脏最大HU值(Max_HU)。
  • 对75例有钙化的患者比较自研脚本与临床计划系统获得的钙化体积/Max_HU值。

主要发现

  • Agatson积分、钙化体积和Max_HU均为高度显著预测因子(p<0.005)。
  • MHD(右/左乳平均±SD:0.8±0.1/2.4±0.7 Gy)仅在按Youden指数最佳截断值(MHD>1 Gy)编码时具有预测价值。
  • 多变量模型结合MHD>1 Gy、年龄和钙化评分,三种评分性能相似(AUC=0.77/0.755,p<0.0001,R2=0.99),三种评分始终为主要预测因子。
  • 计划系统与自研脚本的Max_HU值一致,钙化体积差异较大但高度相关。

关键数值与推荐

  • MHD>1 Gy为基于Youden指数的最佳截断值。
  • Max_HU>250提示中重度钙化,此类左乳腺癌患者从进一步心脏保护中获益最大。

临床怎么用

  • 可利用计划CT自动评估心脏钙化(尤其Max_HU)以快速识别心脏毒性高风险患者。
  • 对左乳腺癌伴中重度钙化(Max_HU>250)者,应考虑进一步心脏保护措施。
  • MHD>1 Gy可作为联合钙化评分和年龄的风险分层指标。

局限性

  • 单中心回顾性研究,结果需外部验证。
  • 钙化体积在自研脚本与计划系统间差异较大。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND PURPOSE: Cardiac calcifications (CAC) are emerging as predictors of cardiac toxicity after breast cancer Radiotherapy. Main purposes of this study were:1) to test the association between CAC scores and cardiac events in a cohort treated with moderate hypo-fractionation; b) to assess interaction between CAC and dosimetry/clinical predictors. MATERIALS AND METHODS: Data of 1172 consecutive patients treated at our hospital with 3DCRT whole breast irradiation (40 Gy/15fr) were available. Heart was automatically segmented and the mean heart dose (MHD) was assessed. The Agatson score (AS), the CAC_volume and the max HU value in the heart (Max_HU) were assessed using an in-house script. Their association with cardiac events was tested by logistic regression, including the combined impact of MHD and relevant clinical parameters (including chemotherapy, age and smoking). CAC_volumes/Max_HU values were compared against the values obtained from our clinical planning system for 75 patients with calcifications. RESULTS: Twenty-nine patients experienced cardiac events (median follow-up:6.5y). AS/CAC_volume/Max_HU were highly significant predictors (p < 0.005). MHD (mean ± SD: 0.8 ± 0.1/2.4 ± 0.7 Gy for right/left) was predictive only if encoded according to the optimal cut-off based on Youden index (MHD > 1 Gy). The resulting multivariate model combined MHD > 1 Gy, age and CAC scores, with similar performances for the three different scores (AUC = 0.77/0.755, p < 0.0001, R2 = 0.99), with the three different scores always being the major predictor. TPS gave consistent values for Max_HU while CAC_volume showed larger differences, although highly correlated. CONCLUSION: CAC are the most important predictors of cardiotoxicity. Max_HU is promising for fast assessment of patients at risk. The greatest clinical benefit of further heart sparing is expected in left breast cancer patients with moderate-severe CAC scores (Max_HU > 250).

来源:Radiother Oncol,查看原文。版权归原作者所有。

引用

  1. Belardo A, Dimayuga KB, Perna L, et al. Density and volume of cardiac calcifications detected on planning CT predicts cardiotoxicity after hypo-fractionated whole breast Radiotherapy. Radiother Oncol. 2025. PMID: 40796017. doi:10.1016/j.radonc.2025.111098

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。